bladder cancer
Showing 1 - 25 of >10,000
Patterns of Urinary Bladder Cancer in Darfur, Suda
Completed
- Urinary Bladder Cancer
-
Darfur, SudanNyala specialized hospital
Nov 27, 2023
Engagement Dynamics Among Individuals Impacted by Bladder Cancer
Not yet recruiting
- Bladder Cancer
-
San Francisco, CaliforniaPower Life Sciences
Aug 18, 2023
Analytical Specificity of Bladder EpiCheck Test in Healthy
Completed
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder EpiCheck
-
San Antonio, TexasUrology San Antonio
Sep 3, 2023
Analyzing Urine During BCG Instillation in Bladder Cancer
Not yet recruiting
- Bladder Cancer
- urine sample collection
-
Shanghai, Shanghai, ChinaChanghai Hospital
Nov 30, 2023
Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)
Recruiting
- Bladder Cancer
- [68Ga]-NOTA-SGC8
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 14, 2023
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
Bladder Cancer Trial in Shibin Al Kawm (CT with contrast, MRI pelvis, TURBT)
Recruiting
- Bladder Cancer
- CT with contrast
- +2 more
-
Shibīn Al Kawm, Menofia, EgyptFaculty of Medicine Menofia University
Sep 14, 2023
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of
Not yet recruiting
- Bladder Cancer
- +3 more
- Geriatric-8 Survey
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Urine-based Molecular Testing vs Cystoscopy for Surveillance of
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- +2 more
- CxBladder Monitor
- Cystoscopy
-
Scottsdale, Arizona
- +2 more
Nov 14, 2023
Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
-
Chengdu, Sichuan, ChinaWest China Hospital
Aug 10, 2023
Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Cystoscopy
- +2 more
- (no location specified)
Apr 4, 2023
Bladder Cancer Trial (Multi4)
Not yet recruiting
- Bladder Cancer
- Multi4
- (no location specified)
Nov 14, 2023
BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder
Recruiting
- Bladder Cancer
-
Little Rock, Arkansas
- +2 more
Aug 6, 2023
Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- (no location specified)
Apr 11, 2023
Addressing Barriers to Palliative Care Use in Bladder Cancer
Completed
- Muscle-Invasive Bladder Carcinoma
- +3 more
- Surveys
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best
Not yet recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Best Practice
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 18, 2023
Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)
Recruiting
- Bladder Cancer
- Pseudomonas aeruginosa
-
Jinan, Shandong, ChinaQilu hospital
Jul 26, 2023
Predicting Post-cystectomy Outcome in Muscle Invasive Bladder
Recruiting
- Bladder Cancer
- develop and validate a deep learning radiomics model based on preoperative enhanced CT image
-
Chongqing, Chongqing, ChinaDepartment of Urology, The First Affiliated Hospital of Chongqin
Oct 18, 2023
AnchorDx UriFind™ Bladder Cancer Assay
Recruiting
- Bladder Cancer
- UriFind Bladder Cancer Assay
-
Little Rock, Arkansas
- +1 more
Dec 6, 2022
Bladder Cancer, Urothelial Carcinoma, Hematuria Trial (Urinalysis)
Not yet recruiting
- Bladder Cancer
- +3 more
- Urinalysis
- (no location specified)
Dec 1, 2022
Bladder Cancer Trial in Tianjin (Cadonilimab)
Recruiting
- Bladder Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 23, 2023
Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive
Recruiting
- Non Muscle Invasive Bladder Cancer
- N803 plus Bacillus Calmette-Guerin (BCG)
-
Honolulu, HawaiiIsland Urology
Aug 7, 2023
T1 Urinary Bladder Cancer Trial in Vienna (Prospective registry)
Recruiting
- T1 Urinary Bladder Cancer
- Prospective registry
-
Vienna, AustriaMedical University of Vienna
Mar 31, 2023
Bladder Cancer Trial (urinary micro RNA detection)
Not yet recruiting
- Bladder Cancer
- urinary micro RNA detection
- (no location specified)
Jan 15, 2023